Jair Jurrjens

Jair Jurrjens’ deal with the Orioles may be unraveling

4 Comments

Jair Jurrjens’ health has been a question mark for some time. It may be a big enough question mark that his deal with the Orioles could unravel. From Eduardo A. Encina of the Baltimore Sun:

As for Jurrjens, it is becoming increasingly unclear whether the one-year deal between him and the Orioles will come to fruition. Vetting his physical has become a week-long process and it doesn’t seem like it’s heading in a positive direction.

The O’s are worried about his knee and his diminished velocity, which may have to do with his knee.  Anyone who saw him pitch for the Braves last year could see that he wasn’t right. He may still not be.

Jurrjens and the O’s have a tentative deal for one year, $1.5 million with incentives that could make worth as much as $4 million.

Drew Pomeranz: “I definitely feel like I can maybe help (as a reliever in the playoffs).”

SAN DIEGO, CALIFORNIA - SEPTEMBER 5:  Drew Pomeranz #31 of the Boston Red Sox pitches during the second inning of a baseball game against the San Diego Padres at PETCO Park on September 5, 2016 in San Diego, California.  (Photo by Denis Poroy/Getty Images)
Denis Poroy/Getty Images
Leave a comment

Red Sox starter Drew Pomeranz hasn’t pitched in a week due to soreness in his left forearm. He threw a bullpen on Thursday afternoon and said, “I definitely feel like I can maybe help (as a reliever in the playoffs,” as ESPN’s Scott Lauber reports.

The Red Sox clinched the AL East on Wednesday, so they don’t need to rush Pomeranz along. And using him out of the bullpen might ultimately be best as he regressed quite a bit after coming to Boston from San Diego in July. In 13 starts with the Red Sox, Pomeranz has a 4.68 ERA with a 69/24 K/BB ratio in 67 1/3 innings.

Eduardo Rodriguez and Clay Buchholz have been throwing the ball quite well as of late. Paired with Rick Porcello and David Price, the Red Sox still have the depth to be menacing in the postseason.

Jesus Montero suspended 50 games for use of a stimulant

Seattle Mariners' Jesus Montero follows through on an RBI-double in the first inning of a spring training baseball game against the Kansas City Royals, Saturday, March 19, 2016, in Surprise, Ariz. (John Sleezer/The Kansas City Star via AP) MANDATORY CREDIT
4 Comments

Remember Jesus Montero? The former Yankees and Mariners prospect? Well, he was picked up by the Blue Jays back in March after the Mariners waived him and played 126 games for Triple-A Buffalo this year. That went alright, I suppose, with Montero hitting .317/.349/.438 with 11 homers. He played a bit of first base too, trying to break the mold he’s been stuck in as a 26-year-old DH.

If this season was a platform for him to make one last push to the bigs, the platform was just pulled out from under him: he has been suspended for 50 games after testing positive for dimethylbutylamine (DMBA), a stimulant in violation of the Minor League Drug Prevention and Treatment Program.

The minor league season is over, of course, so he’ll serve that suspension next season. Assuming the Jays keep him in the fold.